Double filtration plasmapheresis

1 paper3 findings

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

On aging: the drug’s trials ARN judged to be about aging, of every trial that tests it for any use.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

1 lab in 1 country

Humans1

Outcomes

LDL cholesterol

downin humans1

1 study

Double filtration plasmapheresis decreases LDL cholesterol in humans (p <0.001).
“reductions were also observed in total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, and lipoprotein(a), all with p <0.001”
Human trialpatients undergoing two sessions for hypercholesterolemia or hyperlipoproteinemia(a)
Modulating Systemic Immune-Inflammatory Indices via Double Filtration Plasmapheresis: Implications for Aging and Low-Grade Inflammation
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme14 Nov 2025

Latest

1 in 12 months

Hormone and Metabolic Research15 Nov

Modulating Systemic Immune-Inflammatory Indices via Double Filtration Plasmapheresis: Implications for Aging and Low-Grade Inflammation

Cohort study in peopleInterventions

Paper

Double filtration plasmapheresis

Outcomes

Latest

Modulating Systemic Immune-Inflammatory Indices via Double Filtration Plasmapheresis: Implications for Aging and Low-Grade Inflammation

Related